North America Cell Line Development Market 2027 By Type, By Product, Application, and Geography | The Insight Partners

North America Cell Line Development Market to 2027 - Regional Analysis and Forecasts by Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bioproduction and Tissue Engineering); and Geography

Publication Month: Feb 2020 | Report Code: TIPRE00009033 | No. of Pages: 145 | Category: Biotechnology | Status: Published
Covid

Cell Line Development market in North America is expected to grow from US$ 1,393.32 Mn in 2019 to US$ 3,829.46 Mn by the year 2027. This represents a CAGR of 13.5% from the year 2020 to 2027.  

The growth of the Cell Line Development market is driven by the factors such as increase in the demand for innovative products from biopharmaceutical and biotechnology companies, the presence of key market players, and extensive R&D conducted by various academic and research institutes in the North America region.

The medical biotechnology has undergone revolutions as a result of various development programs, business strategies that helps to produce, discover, or alter various biomolecules and organisms through bioengineering approaches. The Biotech Startup Revolution has also assisted in promoting the new ventures holding promising and innovative ideas in the country and supported in maximizing the revenue generation and thus the economic position of North America in the global cell line development market.

Moreover, increasing focus on advanced method incorporation in healthcare, government, and private initiatives for promotion of precision medicine and massive funds from government and private bodies for genomic research are further expected to stimulate growth and contribute to exceptional revenue generation for the cell line development market in North America.

US is anticipated to lead the adoptions of cell line development across the North American region through the forecast period. The increasing investments and rising funds dedicated to the manufacturing companies as well as academic and research institutes for the development of cell line based end products such as precision medicine and other therapeutics is one of the major driving factors. In 2018, The All of Us Research Program of NIH funded the Genome Centers in generating genotype sequence data from bio samples. These factors are expected to accelerate market growth over the forecast years.


Mexico Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)

Mexico Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)

Get more information on this report :



NORTH AMERICA CELL LINE DEVELOPMENT - MARKET SEGMENTATION

North America Cell Line Development Market - By Type

  • Recombinant Cell Line
  • Hybridomas
  • Primary Cell Line
  • Continuous Cell Lines

North America Cell Line Development Market - By Product

  • Media and Reagent
  • Equipment

North America Cell Line Development Market - By Application

  • Bioproduction
  • Drug Discovery
  • Tissue Engineering

North America Cell Line Development Market - By Country

  • U.S.
  • Canada
  • Mexico

Companies Mentioned

  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Sartorius AG
  • SELEXIS
  • BioFactura, Inc.
  • WuXi AppTec
  • LakePharma, Inc.
  • General Electric Company
  • Lonza
  • Corning Incorporated

 

1.           Introduction

1.1         Scope Of The Study

1.2         The Insight Partners Research Report Guidance

2.           North America Cell Line Development Market –  Key Takeaways

3.           North America Cell Line Development Market –  Market Landscape

3.1         Overview

3.2         Market Segmentation

3.2.1        North America Cell Line Development Market – By Type

3.2.2        North America Cell Line Development Market – By Product

3.2.3        North America Cell Line Development Market – By Application

3.2.4        North America Cell Line Development Market – By Country

3.3         PEST Analysis

3.3.1        North America – PEST Analysis

4.           North America Cell Line Development Market- Key Market Dynamics

4.1         Key Market Drivers

4.1.1        Increasing Research and Development Activities

4.1.2        Rising Incidence of Chronic Diseases

4.2         Key Market Restraints

4.2.1        Risk Associated with Cell Line Contamination

4.3         Key Market Opportunities

4.3.1        The Rise in Production of Biosimilars

4.4         Future Trends

4.4.1        Increasing Approvals of Gene/Cell Therapies

4.5         Impact Analysis

5.           Cell Line Development Market – North America Analysis

5.1         North America Cell Line Development Market Revenue Forecasts And Analysis

5.2         Market Positioning

5.3         Performance Of Key Players

5.3.1        Merck KGaA

5.3.2        Thermo Fisher Scientific Inc.

5.4         Expert Opinions

6.           North America Cell Line Development Market Analysis – By Type

6.1         Overview

6.2         North America Cell Line Development Market, By Type, 2018 & 2027 (%)

6.3         North America Cell Line Development Market Revenue And Forecasts To 2027, By Type (US$ Mn)

6.4         Recombinant Cell Line Market

6.4.1        Overview

6.4.2        North America Recombinant Cell Line Market Revenue And Forecasts To 2027(US$ Mn)

6.5         Hybridomas

6.5.1        Overview

6.5.2        North America Hybridoma Market Revenue And Forecasts To 2027 (US$ Mn)

6.6         Primary Cell Line

6.6.1        Overview

6.6.2        North America Primary Cell Line Market Revenue and Forecasts to 2027 (US$ Mn)

6.7         Continuous Cell Lines

6.7.1        Overview

6.7.2        North America Continuous Cell Lines Market Revenue and Forecasts to 2027 (US$ Mn)

7.           North America Cell Line Development Market Analysis – By Product

7.1         Overview

7.2         North America Cell Line Development Market, By Product, 2018 & 2027 (%)

7.3         North America Cell Line Development Market Revenue And Forecasts To 2027, By Product (US$ Mn)

7.4         Media And Reagent Market

7.4.1        Overview

7.4.2        North America Media and Reagent Market Revenue And Forecasts To 2027(US$ Mn)

7.5         Equipment

7.5.1        Overview

7.5.2        North America Equipment Market Revenue And Forecasts To 2027 (US$ Mn)

8.           North America Cell Line Development Market Analysis – By Application

8.1         Overview

8.2         North America Cell Line Development Market, By Application, 2018 & 2027 (%)

8.3         North America Cell Line Development Market Revenue And Forecasts To 2027, By Type (US$ Mn)

8.4         Bioproduction

8.4.1        Overview

8.4.2        North America Bioproduction Market Revenue And Forecasts To 2027(US$ Mn)

8.5         Drug Discovery

8.5.1        Overview

8.5.2        North America Drug Discovery Market Revenue And Forecasts To 2027 (US$ Mn)

8.6         Tissue Engineering

8.6.1        Overview

8.6.2        North America Tissue Engineering Market Revenue And Forecasts To 2027 (US$ Mn)

9.           North America Cell Line Development Market Revenue And Forecasts To 2027

9.1         Overview

9.2         North America Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

9.3         North America Cell Line Development Market Revenue And Forecasts To 2027, By Type (US$ Mn)

9.4         North America Cell Line Development Market Revenue And Forecasts To 2027, By Product (US$ Mn)

9.5         North America Cell Line Development Market Revenue And Forecasts To 2027, By Application (US$ Mn)

9.6         North America Cell Line Development Market Revenue And Forecasts To 2027, By Country (%)

9.7         US Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

9.7.1        US Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)

9.7.2        US Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.7.3        US Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.7.4        US Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.8         Canada Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

9.8.1        Canada Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)

9.8.2        Canada Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.8.3        Canada Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.8.4        Canada Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.9         Mexico Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

9.9.1        Mexico Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)

9.9.2        Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.9.3        Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.9.4        Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.        Cell Line Development Market –Industry Landscape

10.1      Overview

10.2      Growth Strategies in The Cell Line Development Market, (%)

10.3      Organic Developments

10.3.1     Overview

10.3.2     Organic Growth Strategies in the Cell Line Development Market, 2016-2019

10.3.3     Expansion

10.3.3.1       Recent Expansion By Players In The Cell Line Development Market

10.3.4     Inorganic developments

10.3.5     Overview

10.3.6     Inorganic Growth Strategies In The Cell Line Development Market, 2016-2019

10.3.7     Agreements

10.3.7.1       The Cell Line Development Market, By Agreements

10.3.8     Acquisitions

10.3.8.1       Acquisitions By Players In The Cell Line Development Market

11.        Cell Line Development Market – Key Company Profiles

11.1      Merck KGaA

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Financial Overview

11.1.4     Product Portfolio

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Thermo Fisher Scientific, Inc.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Financial Information

11.2.4     Product /Services Portfolio

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Sartorius AG

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Financial Overview

11.3.4     Product Portfolio

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Selexis

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Financial Overview

11.4.4     Product/Service Portfolio

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Biofactura, Inc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Financial Overview

11.5.4     Product Portfolio

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Wuxi AppTec

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Financial Overview

11.6.4     Service Portfolio

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      LakePharma, Inc.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Financial Overview

11.7.4     Product Portfolio

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      General Electric

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Financial Overview

11.8.4     Product Portfolio

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      Lonza

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Financial Information

11.9.4     Product Portfolio

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10   Corning Incorporated

11.10.1  Key Facts

11.10.2  Business Description

11.10.3  Financial Overview

11.10.4  Product Portfolio

11.10.5  SWOT Analysis

11.10.6  Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

12.3      Methodology

12.3.1     Coverage

12.3.2     Secondary Research

12.3.3     Primary Research

LIST OF TABLES

Table 1.            North America Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 2.            North America Cell Line Development Market Revenue And Forecasts to 2027, By product (US$ Mn)

Table 3.            North America Cell Line Development Market Revenue And Forecasts to 2027, By Applicayion (US$ Mn)

Table 4.            North America Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 5.            North America Cell Line Development Market Revenue And Forecasts to 2027, By product (US$ Mn)

Table 6.            North America Cell Line Development Market Revenue And Forecasts to 2027, By application (US$ Mn)

Table 7.            US Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 8.            US Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)

Table 9.            US Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)

Table 10.         Canada Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 11.         Canada Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)

Table 12.         Canada Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)

Table 13.         Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 14.         Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 15.         Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 16.         Recent Expansion in the Cell Line Development Market

Table 17.         The Cell Line Development Market by Agreements

Table 18.         Acquisitions in the Cell Line Development Market

Table 19.         Glossary of Terms, Cell Line Development Market

LIST OF FIGURES

Figure 1.          US Cell Line Development Market, Revenue (US$ Mn), By 2018 & 2027

Figure 2.          North America Cell Line Development Market By Type Market Share (%), 2018

Figure 3.          North America Cell Line Development Market By Product Market Share (%), 2018

Figure 4.          North America Cell Line Development Market By Application Market Share (%), 2018

Figure 5.          Cell Line Development Market Segmentation

Figure 6.          North America PEST Analysis

Figure 7.          Cell Line Development Market Impact Analysis Of Drivers & Restraints

Figure 8.          North America Cell Line Development Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 9.          North America Cell Line Development Market, By Type, 2018 & 2027 (%)

Figure 10.       North America Recombinant Cell Line Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 11.       North America Hybridoma Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 12.       North America Primary Cell Line Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 13.       North America Continuous Cell Lines Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 14.       North America Cell Line Development Market, By Product, 2018 & 2027 (%)

Figure 15.       North America Media And Reagent Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16.       North America Equipment Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 17.       North America Cell Line Development Market, By Application, 2018 & 2027 (%)

Figure 18.       North America Bioproduction Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.       North America Drug Discovery Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.       North America Tissue Engineering Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 21.       North America Cell Line Development Market Revenue, By Country, 2018 (US$ Mn)

Figure 22.       North America Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 23.       North America Cell Line Development Market Revenue And Forecasts To 2027, By Country (%)

Figure 24.       US Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 25.       Canada Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 26.       Mexico Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 27.       Growth Strategies in The Cell Line Development Market, (%)

Figure 28.       Organic Growth Strategies In The Cell Line Development Market, 2016-2019

Figure 29.       Inorganic Developments In The Cell Line Development Market, 2016-2019

The List of Companies - North America Cell Line Development Market

 

  1. Merck KGaA
  2. Thermo Fisher Scientific, Inc.
  3. Sartorius AG
  4. SELEXIS
  5. BioFactura, Inc.
  6. WuXi AppTec
  7. LakePharma, Inc.
  8. General Electric Company
  9. Lonza
  10. Corning Incorporated

 

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell line development market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the North America cell line development market market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPRE00009033
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing